Transparency
Widely recognized as a leading voice for thalassemia patients and their families, ATF’s (Abdul Aziz Thalassemia Foundation) requires sustainable funding to effectively carry out its mission of advocating for patients and supporting the development and implementation of comprehensive thalassemia control programs, including prevention, early diagnosis, treatment, and clinical management.
ATF’s funding is derived from a variety of sources, including national, regional, and international grants and funds, philanthropic foundations, corporate partners, generous individual donors, healthcare organizations, and other institutions that share a common commitment to improving the lives of individuals affected by thalassemia and other haemoglobin disorders.
To maintain its independence and credibility, ATF’s ensures that all funding relationships are managed with transparency, accountability, and in accordance with the Foundation’s mission, values, and commitment to serving the best interests of patients and their families.
As a patient-driven organization, ATF’s (Abdul Aziz Thalassemia Foundation ) is committed to maintaining its independence, integrity, and autonomy. ATF’s will make decisions, adopt positions, and undertake activities based solely on the needs, interests, and perspectives of patients and their families.
The organization will ensure that all its policies, partnerships, and priorities are guided by its mission to improve patient care, treatment outcomes, quality of life, and overall well-being. ATF’s remains dedicated to acting in the best interests of patients at all times and will not allow external, commercial, or other interests to influence its decisions or advocacy efforts.